Introduction of Institute of Stroke
The major research directions of the Institute of Stroke are (i) epidemiologic study on stroke; (ii) monitoring and research of stroke in the Beijing area; (iii) genomics research on stroke; (iv) proteomics research on stroke; (v) pathophysiological research on cerebral ischemia and hemorrhage; (vi) pre-clinical evaluation research on stroke drugs; (vii) outcome research on stroke; (viii) clinical trial research on stroke; (ix) relevant imageological researches on stroke; (x) construction and application research of clinical resources and sample bank of stroke; (xi) non-drug treatment research on stroke; (xii) kinetic research on cerebral blood flow; (xiii) research on vascular aging and functional reconstruction. The Institute of Stroke consists of 13 research offices including Stroke Epidemiological Research Office, Stroke Monitoring Research Office in Beijing Area, Stroke Genomics Research Office, Stroke Proteomics Research Office, Cerebral Ischemia and Hemorrhage Pathophysiology Research Office, Pre-clinical Stroke Drugs Evaluation Research Office, Stroke Outcome Research Office, etc., up to a total of . There are 13 PIs in the Institute of Stroke.
Ph.D. in Molecular Physiology, 2002 University of Iowa, Iowa City, Iowa
Jie Lu, female, born in 1975. Professor/Chief physician, PhD supervisor, Co-director of Department of Nnuclear Medicine, Xuanwu Hospital of Capital Medical University.
Luo Yumin, born in 1965, professor of neurology and director of Cerebrovascular Diseases Research Institute of Capital Medical University.
Professor, Chief Physician, and Doctoral Tutor of Neurology, Xuanwu Hospital , Capital Medical University
Professor and Chair, Department of Pharmacology
Second Military Medical University, Shanghai, China
Associate Professor of Institute of Hypoxia Medicine Xuanwu Hospital, Capital Medical University.
Wen Wang, born in 1968, Professor, Tutors for Doctor degree candidates, Director of Laboratory Animal Center of Xuanwu Hospital, Capital Medical University.
I have extensive research experience and clinical neurology expertise to serve as co-PI for the proposed trial. I have a great deal of experience conducting clinical studies in acute ischemic stroke and clinical trials in China.